In clinical trials, levocloperastine was generally well tolerated, with mild and transient nausea the only adverse event reported. There was no evidence of central adverse events with ...

The pharmacokinetic behaviour of levocloperastine observed in animal studies has been confirmed in human studies. The pharmacokinetics of levocloperastine and racemic DL-cloperastine were ...